EDGAR Filing Documents for 0001193125-11-340979

Form 8-K - Current report:

SEC Accession No. 0001193125-11-340979

Filing Date

2011-12-14

Accepted

2011-12-14 16:42:57

Documents

Period of Report

2011-12-08

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d271168d8k.htm	8-K	29976
2	LETTER AGREEMENT	d271168dex11.htm	EX-1.1	93697
3	ARTICLES OF AMENDMENT	d271168dex31.htm	EX-3.1	80191
4	FORM OF SERIES 14 PREFERRED STOCK CERTIFICATE	d271168dex41.htm	EX-4.1	7382
5	FORM OF COMMON STOCK PURCHASE WARRANT	d271168dex42.htm	EX-4.2	72292
6	OPINION OF KARR TUTTLE CAMPBELL	d271168dex51.htm	EX-5.1	14231
7	FORM OF SECURITIES PURCHASE AGREEMENT	d271168dex101.htm	EX-10.1	154344
8	PRESS RELEASE	d271168dex991.htm	EX-99.1	9613
9	GRAPHIC	g271168g10r77.jpg	GRAPHIC	23112
10	GRAPHIC	g271168g22k69.jpg	GRAPHIC	3091
11	GRAPHIC	g271168g84y60.jpg	GRAPHIC	4940
	Complete submission text file	0001193125-11-340979.txt		506411

Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119

Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100

CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)